CoChat

Leukotriene B4 Mediates Neutrophil Migration Induced by Heme

Open access
Monteiro, Ana Paula T, Pinheiro, Carla S, Luna-Gomes, Tatiana, Alves, Liliane R, Maya-Monteiro, Clarissa M, Porto, Barbara N, Barja-Fidalgo, Christina, Benjamim, Claudia F, Peters-Golden, Marc, Bandeira-Melo, Christianne, Bozza, Marcelo T, Canetti, Claudio · 2011 · The Journal of Immunology
Cited by 61

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

High concentrations of free heme found during hemolytic events or cell damage leads to inflammation, characterized by neutrophil recruitment and production of reactive oxygen species, through mechanisms not yet elucidated. In this study, we provide evidence that heme-induced neutrophilic inflammation depends on endogenous activity of the macrophage-derived lipid mediator leukotriene B4 (LTB4). In vivo, heme-induced neutrophil recruitment into the peritoneal cavity of mice was attenuated by pretreatment with 5-lipoxygenase (5-LO) inhibitors and leukotriene B4 receptor 1 (BLT1) receptor antagonists as well as in 5-LO knockout (5-LO−/−) mice. Heme administration in vivo increased peritoneal levels of LTB4 prior to and during neutrophil recruitment. Evidence that LTB4 was synthesized by resident macrophages, but not mast cells, included the following: 1) immuno-localization of heme-induced LTB4 was compartmentalized exclusively within lipid bodies of resident macrophages; 2) an increase in the macrophage population enhanced heme-induced neutrophil migration; 3) depletion of resident mast cells did not affect heme-induced LTB4 production or neutrophil influx; 4) increased levels of LTB4 were found in heme-stimulated peritoneal cavities displaying increased macrophage numbers; and 5) in vitro, heme was able to activate directly macrophages to synthesize LTB4. Our findings uncover a crucial role of LTB4 in neutrophil migration induced by heme and suggest that beneficial therapeutic outcomes could be achieved by targeting the 5-LO pathway in the treatment of inflammation associated with hemolytic processes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4049/jimmunol.1002400

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 38

  1. Eiam-Ong, 1998, Falciparum malaria and the kidney: a model of inflammation, Am. J. Kidney Dis., 32, 361, 10.1053/ajkd.1998.v32.pm9740151 · doi:10.1053/ajkd.1998.v32.pm9740151
  2. Baca, 1988, The HELLP syndrome: a serious complication of pregnancy with hemolysis, elevated levels of liver enzymes, and low platelet count, Am. J. Med., 85, 590, 10.1016/S0002-9343(88)80114-1 · DOI
  3. Balla, 1991, Hemin: a possible physiological mediator of low density lipoprotein oxidation and endothelial injury, Arterioscler. Thromb., 11, 1700, 10.1161/01.ATV.11.6.1700 · DOI · Paper page
  4. Solovey, 1999, Sickle cell anemia as a possible state of enhanced anti-apoptotic tone: survival effect of vascular endothelial growth factor on circulating and unanchored endothelial cells, Blood, 93, 3824, 10.1182/blood.V93.11.3824 · DOI · Paper page
  5. Belcher, 2000, Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion, Blood, 96, 2451, 10.1182/blood.V96.7.2451 · DOI · Paper page
  6. Kaul, 2004, Anti-inflammatory therapy ameliorates leukocyte adhesion and microvascular flow abnormalities in transgenic sickle mice, Am. J. Physiol. Heart Circ. Physiol., 287, H293, 10.1152/ajpheart.01150.2003 · DOI · Paper page
  7. Croizat, 1999, Circulating cytokines response and the level of erythropoiesis in sickle cell anemia, Am. J. Hematol., 60, 105, 10.1002/(SICI)1096-8652(199902)60:2<105::AID-AJH4>3.0.CO;2-Z · doi:10.1002/(sici)1096-8652(199902)60:2<105::aid-ajh4>3.0.co;2-z
  8. Abraham, 1985, Effect of age on rat liver heme and drug metabolism, Exp. Gerontol., 20, 277, 10.1016/0531-5565(85)90053-1 · DOI
  9. Abraham, 1988, Expression of heme oxygenase gene in rat and human liver, Biochem. Biophys. Res. Commun., 150, 717, 10.1016/0006-291X(88)90450-0 · doi:10.1016/0006-291x(88)90450-0
  10. Beri, 1993, Chemistry and biology of heme. Effect of metal salts, organometals, and metalloporphyrins on heme synthesis and catabolism, with special reference to clinical implications and interactions with cytochrome P-450, Drug Metab. Rev., 25, 49, 10.3109/03602539308993973 · DOI · Paper page
  11. Sassa, 1996, The role of heme in gene expression, Int. J. Hematol., 63, 167, 10.1016/0925-5710(96)00449-5 · DOI
  12. Ponka, 1999, Cell biology of heme, Am. J. Med. Sci., 318, 241, 10.1016/S0002-9629(15)40628-7 · DOI · Paper page
  13. Springer, 1994, Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm, Cell, 76, 301, 10.1016/0092-8674(94)90337-9 · DOI · Paper page
  14. Graça-Souza, 2002, Neutrophil activation by heme: implications for inflammatory processes, Blood, 99, 4160, 10.1182/blood.V99.11.4160 · DOI · Paper page
  15. Peters-Golden, 2007, Leukotrienes, N. Engl. J. Med., 357, 1841, 10.1056/NEJMra071371 · DOI · Paper page
  16. Ibe, 1994, Plasma and urinary leukotrienes in sickle cell disease: possible role in the inflammatory process, Eur. J. Clin. Invest., 24, 57, 10.1111/j.1365-2362.1994.tb02060.x · DOI
  17. Setty, 2003, Hypoxaemia in sickle cell disease: biomarker modulation and relevance to pathophysiology, Lancet, 362, 1450, 10.1016/S0140-6736(03)14689-2 · DOI · Paper page
  18. Setty, 2002, Eicosanoids in sickle cell disease: potential relevance of neutrophil leukotriene B4 to disease pathophysiology, J. Lab. Clin. Med., 139, 80, 10.1067/mlc.2002.121200 · DOI
  19. Palmblad, 1982, Effects of novel leukotrienes on neutrophil migration, FEBS Lett., 144, 81, 10.1016/0014-5793(82)80573-5 · doi:10.1016/0014-5793(82)80573-5
  20. Lindbom, 1982, Leukotriene B4 induces extravasation and migration of polymorphonuclear leukocytes in vivo, Acta Physiol. Scand., 116, 105, 10.1111/j.1748-1716.1982.tb10607.x · doi:10.1111/j.1748-1716.1982.tb10607.x
  21. Canetti, 2001, Tumour necrosis factor-alpha and leukotriene B(4) mediate the neutrophil migration in immune inflammation, Br. J. Pharmacol., 134, 1619, 10.1038/sj.bjp.0704403 · DOI
  22. Oliveira, 2008, Neutrophil migration induced by IL-1beta depends upon LTB4 released by macrophages and upon TNF-alpha and IL-1beta released by mast cells, Inflammation, 31, 36, 10.1007/s10753-007-9047-x · DOI
  23. Canetti, 2003, IL-18 enhances collagen-induced arthritis by recruiting neutrophils via TNF-alpha and leukotriene B4, J. Immunol., 171, 1009, 10.4049/jimmunol.171.2.1009 · DOI · Paper page
  24. Ramos, 2005, MIP-1alpha[CCL3] acting on the CCR1 receptor mediates neutrophil migration in immune inflammation via sequential release of TNF-alpha and LTB4, J. Leukoc. Biol., 78, 167, 10.1189/jlb.0404237 · DOI · Paper page
  25. Ramos, 2006, Neutrophil recruitment in immunized mice depends on MIP-2 inducing the sequential release of MIP-1alpha, TNF-alpha and LTB(4), Eur. J. Immunol., 36, 2025, 10.1002/eji.200636057 · DOI
  26. Muller-Eberhard, 1968, Plasma concentrations of hemopexin, haptoglobin and heme in patients with various hemolytic diseases, Blood, 32, 811, 10.1182/blood.V32.5.811.811 · DOI · Paper page
  27. Kasschau, 1996, Adhesion of sickle neutrophils and erythrocytes to fibronectin, Blood, 87, 771, 10.1182/blood.V87.2.771.bloodjournal872771 · DOI · Paper page
  28. Hofstra, 1996, Sickle erythrocytes adhere to polymorphonuclear neutrophils and activate the neutrophil respiratory burst, Blood, 87, 4440, 10.1182/blood.V87.10.4440.bloodjournal87104440 · DOI · Paper page
  29. Fadlon, 1998, Blood polymorphonuclear leukocytes from the majority of sickle cell patients in the crisis phase of the disease show enhanced adhesion to vascular endothelium and increased expression of CD64, Blood, 91, 266, 10.1182/blood.V91.1.266 · DOI · Paper page
  30. Mollapour, 1998, Raised neutrophil phospholipase A2 activity and defective priming of NADPH oxidase and phospholipase A2 in sickle cell disease, Blood, 91, 3423, 10.1182/blood.V91.9.3423 · DOI
  31. Lard, 1999, Neutrophil activation in sickle cell disease, J. Leukoc. Biol., 66, 411, 10.1002/jlb.66.3.411 · DOI · Paper page
  32. Field, 2009, Urinary cysteinyl leukotriene E(4) is associated with increased risk for pain and acute chest syndrome in adults with sickle cell disease, Am. J. Hematol., 84, 158, 10.1002/ajh.21348 · DOI
  33. Patel, 2009, Placenta growth factor induces 5-lipoxygenase-activating protein to increase leukotriene formation in sickle cell disease, Blood, 113, 1129, 10.1182/blood-2008-07-169821 · DOI
  34. Ribeiro, 1991, IL-8 causes in vivo neutrophil migration by a cell-dependent mechanism, Immunology, 73, 472
  35. Ribeiro, 1997, Role of resident mast cells and macrophages in the neutrophil migration induced by LTB4, fMLP and C5a des arg, Int. Arch. Allergy Immunol., 112, 27, 10.1159/000237427 · DOI
  36. Oliveira, 1997, Participation of interleukin-5, interleukin-8 and leukotriene B4 in eosinophil accumulation in two different experimental models, Mem. Inst. Oswaldo Cruz, 92, 205, 10.1590/S0074-02761997000800028 · DOI
  37. Ajuebor, 1999, Role of resident peritoneal macrophages and mast cells in chemokine production and neutrophil migration in acute inflammation: evidence for an inhibitory loop involving endogenous IL-10, J. Immunol., 162, 1685, 10.4049/jimmunol.162.3.1685 · DOI · Paper page
  38. Bozza, 2009, Leukocyte lipid bodies - biogenesis and functions in inflammation, Biochim. Biophys. Acta, 1791, 540, 10.1016/j.bbalip.2009.01.005 · DOI · Paper page

Cited by

See all 61

Metadata

Authors
Monteiro, A. P. T., Pinheiro, C. S., Luna-Gomes, T., Alves, L. R., Maya-Monteiro, C. M., Porto, B. N., Barja-Fidalgo, C., Benjamim, C. F., Peters-Golden, M., Bandeira-Melo, C., Bozza, M. T., & Canetti, C.
Venue
The Journal of Immunology
Published
2011-06-01
Volume
186
Issue
11
Pages
6562-6567
ISSN
  • 0022-1767 (ISSN-L)
  • 1550-6606
OpenAlex
W2102456349
Cited by
61
References
5
FWCI
3.76
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.